scholarly journals Factors Affecting Destination Choice in Medical Tourism

2020 ◽  
Vol 8 (2) ◽  
pp. 80-88 ◽  
Author(s):  
Haşim Çapar ◽  
Özgür Aslan

Introduction: Although many factors can affect the choice of destination in medical tourism, some factors are indispensable to medical tourists and medical tourism. The aim of this study was to analyze important factors affecting the selection of a destination by potential medical tourists. Methods: This descriptive, cross-sectional study, conducted in Turkey, included a population of 1700 people and a sample size of 317 people selected through purposive sampling. Values were evaluated with a 95% confidence interval and 0.05 standard error. A value of P<0.05 was considered statistically significant. The medical tourism scale and a demographic information form were used in data collection. Exploratory factor analysis (EFA), confirmatory factor analysis (CFA), and path analysis were used as statistical methods. Analyses were made using IBM SPSS-AMOS 25.0. Results: In this study, 56.5% of the participants were male and 43.5% were female. The factors affecting the selection of medical tourism destinations were determined to be, in order of importance, accessibility of health care service (X̄ = 4.68 ± 1.073), level of security and safety (X̄ = 4:57 ± 1.122), quality of health care service (X̄ = 4:39 ± 1.129), level of hygiene (X̄ = 4.16 ± 1.381), potential of savings-low cost (X̄ = 4.07 ± 1.447), and tourism opportunities (X̄ = 4.02 ± 1.540). Conclusion: It is thought that the current study will make a serious contribution to the field of medical tourism both in practice and in theory.

2018 ◽  
Vol 68 (3) ◽  
pp. 176-182 ◽  
Author(s):  
Satar Rezaei ◽  
Abraha Woldemichael ◽  
Hamed Zandian ◽  
Enayatollah Homaie Rad ◽  
Navid Veisi ◽  
...  

Author(s):  
Vidhyashree Sampath-Arutperumselvi ◽  
Aruna Gorugantu ◽  
Sherin Hamza ◽  
Mahjouba Ahmid Ahmid ◽  
Alison Kelly

Author(s):  
Zahra Aajami ◽  
Abbas Kebriaeezadeh ◽  
Shekoufeh Nikfar

Background: Alzheimer’s disease (AD) affects a large number of adults annually all around the world. The monetary cost of this disorder is huge. This study aims to estimate the cost of AD in Iran by considering stages of disease. Methods: A cross-sectional study was designed from July to December 2017 on 300 AD cases who referred to the Iran Alzheimer’s Association, Tehran, Iran. To calculate costs at different stages of disease, patients were assigned into three groups, based on the MiniMental State Exam (MMSE) score. A list of medicines’ prices and health care service costs were prepared. Health care services’ cost was acquired from the book of “Relative value units of health care services in Iran” and the price of medicines was extracted from "Iran’s medicine triple prices list". Patients’ medical records and face to face interview with their caregivers were used for data collection. The perspective of present research was societal. Results: Annually, per person cost of AD in mild, moderate, and severe stages of disease were 434 United States dollars (USD), 1313 USD, and 2480 USD, respectively. Direct non-medical costs (DNMC) had the greatest share of total costs (near half of the whole costs) including 263 USD, 641 USD, and 1257 USD for mild, moderate, and severe stages, respectively. Conclusion: The cost of AD in Iran is lower than the average cost of dementia in upper middle-income countries. In all stages, the biggest part of the cost is associated with patient care and nursing services because patients suffering from AD usually require specialized cares. 


2015 ◽  
Vol 49 (0) ◽  
Author(s):  
Paulo Afonso Martins Abati ◽  
Aluisio Cotrim Segurado

OBJECTIVE To analyze the clinical and laboratory characteristics of HIV-infected individuals upon admission to a reference health care center.METHODS This cross-sectional study was conducted between 1999 and 2010 on 527 individuals with confirmed serological diagnosis of HIV infection who were enrolled in an outpatient health care service in Santarém, PA, Northern Brazil. Data were collected from medical records and included the reason for HIV testing, clinical status, and count of peripheral CD4+ T lymphocytes upon enrollment. The data were divided into three groups, according to the patient’s year of admission – P1 (1999-2002), P2 (2003-2006), and P3 (2007-2010) – for comparative analysis of the variables of interest.RESULTS In the study group, 62.0% of the patients were assigned to the P3 group. The reason for undergoing HIV testing differed between genders. In the male population, most tests were conducted because of the presence of symptoms suggesting infection. Among women, tests were the result of knowledge of the partner’s seropositive status in groups P1 and P2. Higher proportion of women undergoing testing because of symptoms of HIV/AIDS infection abolished the difference between genders in the most recent period. A higher percentage of patients enrolling at a more advanced stage of the disease was observed in P3.CONCLUSIONS Despite the increased awareness of the number of HIV/AIDS cases, these patients have identified their serological status late and were admitted to health care units with active disease. The HIV/AIDS epidemic in Pará presents specificities in its progression that indicate the complex characteristics of the epidemic in the Northern region of Brazil and across the country.


Sign in / Sign up

Export Citation Format

Share Document